Boston Scientific (BSX) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Boston Scientific · Health Care · ref. ETF XLV · 99 calls · price $46.67
What the company does: Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe.
📈 Boston Scientific (BSX) stock price
$46.67-55.9% over range
Aug 28, 25low $42.63 · high $108.14Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
86% recommend buying · 22 analysts
📊 JPI status : Boston Scientific is no longer in our current JPI rankings, but appeared in the past (2018, 2017) — its upside may be behind it. See the stocks picked in 2018 →
🎯 BSX price target & analyst consensus — price $46.67
The price target · all analysts combined (20 targets)
Highest target · 1 firm of 20$89+90.7%
Median target · of 20 targets$67+43.6%
Lowest target · 1 firm of 20$50+7.1%
Current price$46.67
Where these 20 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
20100%
$50 ↔ $89
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Jefferies — 72% of its targets hit on this sector (380 calls tested). It aims for $67 (+44 %), call made on June 25, 2026, maturing on June 25, 2027 (64 d ago).
The 12 reliable analysts
$63+35 %
The 8 other firms
$74.50+60 %
How to read it: the 12 reliable firms are not filtered by optimism — 12 aim above the price, 0 below, hence their $63 median. “The 8 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 22 ratings (last 6 months)
Strong Buy00%
Buy1986%
Hold314%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 BSX price target all
All 23 calls, one by one, with our verdict on each firm.
→ See all 23 targets, analyst by analyst💡 The best analysts on BSX most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in BSX? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Boston Scientific? The JPI assistant answers using our backtest data.
📈 Boston Scientific fundamentals: valuation, margins & growth › open the full page
P/E 19.5Net margin 17.5 %Revenue growth +7.5 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 5 %
2023
Rev +12%Profit +145%
2024
Rev +18%Profit +18%
2025
Rev +20%Profit +56%
🏛️ Boston Scientific insider buying: who's buying and how much › open the full page
5 insiders bought8 buys / 6 mo $10.0M👥 Cluster buy
🔎 Detailed analyses
🏛️ Which US Congress members hold Boston Scientific (BSX)?
1 Congress member has disclosed BSX buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Lois Frankel 2× · 45%
✅ Historical analyst reliability on BSX
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Mizuho ↗ | 100% | +39.9% | 4 |
| Stephens & Co. ↗ | 100% | +33.1% | 2 |
| TD Cowen ↗ | 100% | +31.8% | 5 |
| Bernstein ↗ | 100% | +30.5% | 3 |
| B of A Securities ↗ | 100% | +29.1% | 3 |
| SunTrust Robinson Humphrey | 100% | +28.8% | 2 |
| Argus Research ↗ | 100% | +25.4% | 6 |
| Leerink Swann | 100% | +23.5% | 3 |
| Jefferies ↗ | 100% | +19.5% | 3 |
| BMO Capital ↗ | 100% | +16.8% | 3 |
See the other 19 firms
| Cowen & Co. | 50% | -5.3% | 2 |
| Baird ↗ | 57% | +8.1% | 7 |
| Goldman Sachs ↗ | 67% | +0.2% | 3 |
| Wells Fargo ↗ | 71% | +15.7% | 14 |
| Truist Securities ↗ | 73% | +11.5% | 15 |
| Raymond James ↗ | 73% | +14.4% | 26 |
| Piper Sandler ↗ | 75% | +13.3% | 4 |
| UBS ↗ | 75% | +16.4% | 8 |
| Barclays ↗ | 76% | +22.1% | 17 |
| Morgan Stanley ↗ | 77% | +15.1% | 22 |
| Needham ↗ | 83% | +28.2% | 24 |
| Credit Suisse | 83% | +40.1% | 6 |
| Evercore ISI Group ↗ | 86% | +20.4% | 7 |
| Canaccord Genuity ↗ | 86% | +23.1% | 14 |
| JP Morgan ↗ | 88% | +23.9% | 8 |
| RBC Capital ↗ | 88% | +30.2% | 17 |
| Stifel ↗ | 88% | +36.7% | 17 |
| BTIG ↗ | 90% | +27.3% | 10 |
| Citigroup ↗ | 92% | +30.8% | 24 |
📊 What $1,000 invested in Boston Scientific would be worth › open the full page
In short — $1,000 invested in Boston Scientific 10 years ago would be worth $2,315 today, i.e. +9%/yr on average. Best year: 2024 (+55%), worst: 2020 (-20%). Price performance, excluding dividends.
If I'd invested $1,000 in Boston Scientific
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $478 | -52% |
| 3 years ago | $922 | -8% |
| 5 years ago | $1,187 | +19% |
Return by year (Boston Scientific)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -55% | $448 (-55%) |
| 2025 | +7% | $478 (-52%) |
| 2024 | +55% | $738 (-26%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Boston Scientific
Loading news…
📋 All analyst calls on BSX
Filtered on — · ✕ show all
▲ Buy · 🎯$56
Price at call : $48.17 — upside +16%
Today : $46.67 — upside +20%
🎯 on BSX : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Aug 25, 27
matures : Aug 25, 27
Argus Research ↗
Jul 31, 26
■ Hold neutral · not a buy
🎯 on BSX : no call matured yet · 📊 on Health : 55.7% · +2.6% (158 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
▲ Buy · 🎯$67
Price at call : $46.73 — upside +43%
Today : $46.67 — upside +44%
🎯 on BSX : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
▲ Buy · 🎯$61
Price at call : $46.73 — upside +31%
Today : $46.67 — upside +31%
🎯 on BSX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
RBC Capital ↗
Jul 30, 26
▲ Outperform · 🎯$70
Price at call : $46.73 — upside +50%
Today : $46.67 — upside +50%
🎯 on BSX : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
▲ Buy · 🎯$56
Price at call : $46.73 — upside +20%
Today : $46.67 — upside +20%
🎯 on BSX : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Canaccord Genuity ↗
Jul 30, 26
▲ Buy · 🎯$66
Price at call : $46.73 — upside +41%
Today : $46.67 — upside +41%
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Truist Securities ↗
Jul 30, 26
▲ Buy · 🎯$57
Price at call : $46.73 — upside +22%
Today : $46.67 — upside +22%
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
See the other 91 calls, newest to oldest
Evercore ISI Group ↗
Jul 30, 26
▲ Outperform · 🎯$55
Price at call : $46.73 — upside +18%
Today : $46.67 — upside +18%
🎯 on BSX : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Wells Fargo ↗
Jul 30, 26
■ Equal-Weight neutral · not a buy · 🎯$50
Price at call : $46.73 — gap to target +7%
Today : $46.67 — gap to target +7%
🎯 on BSX : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
▲ Buy · 🎯$60
Price at call : $46 — upside +30%
Today : $46.67 — upside +29%
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
Oppenheimer ↗
Jul 27, 26
▲ Outperform · 🎯$85
Price at call : $45.51 — upside +87%
Today : $46.67 — upside +82%
🎯 on BSX : no call matured yet · 📊 on Health : 44.1% · +0.6% (220 calls)
in progress (365j)
matures : Jul 27, 27
matures : Jul 27, 27
Truist Securities ↗
Jul 16, 26
▲ Buy · 🎯$62
Price at call : $44.03 — upside +41%
Today : $46.67 — upside +33%
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
▲ Outperform · 🎯$70
Price at call : $44.62 — upside +57%
Today : $46.67 — upside +50%
🎯 on BSX : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
RBC Capital ↗
Jul 13, 26
▲ Outperform · 🎯$85
Price at call : $42.63 — upside +99%
Today : $46.67 — upside +82%
🎯 on BSX : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
▲ Buy · 🎯$57
Price at call : $44.81 — upside +27%
Today : $46.67 — upside +22%
🎯 on BSX : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$65
Price at call : $45.3 — upside +43%
Today : $46.67 — upside +39%
🎯 on BSX : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Buy · 🎯$65
Price at call : $44.23 — upside +47%
Today : $46.67 — upside +39%
🎯 on BSX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jun 25, 27
matures : Jun 25, 27
▲ Buy · 🎯$67
Price at call : $44.2 — upside +52%
Today : $46.67 — upside +44%
🎯 on BSX : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
▲ Buy · 🎯$65
Price at call : $46.92 — upside +39%
Today : $46.67 — upside +39%
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jun 16, 27
matures : Jun 16, 27
Truist Securities ↗
Jun 4, 26
▲ Buy · 🎯$64
Price at call : $48.85 — upside +31%
Today : $46.67 — upside +37%
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▲ Buy · 🎯$65
Price at call : $47.69 — upside +36%
Today : $46.67 — upside +39%
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
Canaccord Genuity ↗
Jun 1, 26
▲ Buy · 🎯$70
Price at call : $47.68 — upside +47%
Today : $46.67 — upside +50%
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : Jun 1, 27
matures : Jun 1, 27
Wolfe Research ↗
May 29, 26
■ Peer Perform neutral · not a buy
🎯 on BSX : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : May 29, 27
matures : May 29, 27
▲ Buy · 🎯$70
Price at call : $48.31 — upside +45%
Today : $46.67 — upside +50%
🎯 on BSX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
Leerink Partners ↗
May 28, 26
▲ Outperform · 🎯$74
Price at call : $48.31 — upside +53%
Today : $46.67 — upside +59%
🎯 on BSX : 0% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
▲ Overweight · 🎯$89
Price at call : $48.31 — upside +84%
Today : $46.67 — upside +91%
🎯 on BSX : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
Wells Fargo ↗
May 28, 26
■ Equal-Weight neutral · not a buy · 🎯$55
Price at call : $48.31 — gap to target +14%
Today : $46.67 — gap to target +18%
🎯 on BSX : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
▲ Outperform · 🎯$75
Price at call : $56.81 — upside +32%
Today : $46.67 — upside +61%
🎯 on BSX : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : May 19, 27
matures : May 19, 27
B of A Securities ↗
May 18, 26
▲ Buy · 🎯$68
Price at call : $56.81 — upside +20%
Today : $46.67 — upside +46%
🎯 on BSX : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
▲ Buy · 🎯$77
Price at call : $56.81 — upside +36%
Today : $46.67 — upside +65%
🎯 on BSX : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
▲ Buy · 🎯$80
Price at call : $56.81 — upside +41%
Today : $46.67 — upside +71%
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : May 18, 27
matures : May 18, 27
Canaccord Genuity ↗
Apr 23, 26
▲ Buy · 🎯$71
Price at call : $62.07 — upside +14%
Today : $46.67 — upside +52%
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
RBC Capital ↗
Apr 23, 26
▲ Outperform · 🎯$100
Price at call : $62.07 — upside +61%
Today : $46.67 — upside +114%
🎯 on BSX : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Overweight · 🎯$96
Price at call : $62.07 — upside +55%
Today : $46.67 — upside +106%
🎯 on BSX : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Evercore ISI Group ↗
Apr 23, 26
▲ Outperform · 🎯$78
Price at call : $62.07 — upside +26%
Today : $46.67 — upside +67%
🎯 on BSX : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Wells Fargo ↗
Apr 23, 26
▲ Overweight · 🎯$75
Price at call : $62.07 — upside +21%
Today : $46.67 — upside +61%
🎯 on BSX : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Truist Securities ↗
Apr 23, 26
▲ Buy · 🎯$85
Price at call : $65.69 — upside +29%
Today : $46.67 — upside +82%
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Outperform · 🎯$78
Price at call : $65.69 — upside +19%
Today : $46.67 — upside +67%
🎯 on BSX : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Goldman Sachs ↗
Apr 23, 26
▲ Buy · 🎯$84
Price at call : $65.69 — upside +28%
Today : $46.67 — upside +80%
🎯 on BSX : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Buy · 🎯$77
Price at call : $65.69 — upside +17%
Today : $46.67 — upside +65%
🎯 on BSX : no call matured yet · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Buy · 🎯$100
Price at call : $65.69 — upside +52%
Today : $46.67 — upside +114%
🎯 on BSX : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
▲ Overweight · 🎯$100
Price at call : $64.87 — upside +54%
Today : $46.67 — upside +114%
🎯 on BSX : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
▲ Buy · 🎯$80
Price at call : $64.87 — upside +23%
Today : $46.67 — upside +71%
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
▲ Buy · 🎯$85
Price at call : $59.52 — upside +43%
Today : $46.67 — upside +82%
🎯 on BSX : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Apr 21, 27
matures : Apr 21, 27
Truist Securities ↗
Apr 15, 26
▲ Buy · 🎯$90
Price at call : $63.42 — upside +42%
Today : $46.67 — upside +93%
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
▲ Outperform · 🎯$90
Price at call : $63.82 — upside +41%
Today : $46.67 — upside +93%
🎯 on BSX : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
▲ Buy · 🎯$87
Price at call : $62.56 — upside +39%
Today : $46.67 — upside +86%
🎯 on BSX : no call matured yet · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Apr 7, 27
matures : Apr 7, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$80
Price at call : $61.86 — upside +29%
Today : $46.67 — upside +71%
🎯 on BSX : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
RBC Capital ↗
Mar 30, 26
▲ Outperform · 🎯$115
Price at call : $62.75 — upside +83%
Today : $46.67 — upside +146%
🎯 on BSX : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Mar 30, 27
matures : Mar 30, 27
Raymond James ↗
Mar 30, 26
▲ Outperform · 🎯$88
Price at call : $62.75 — upside +40%
Today : $46.67 — upside +89%
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
in progress (365j)
matures : Mar 30, 27
matures : Mar 30, 27
Leerink Partners ↗
Oct 1, 25
▲ Outperform · 🎯$128
Price at call : $95.85 — upside +34%
Today : $46.67 — upside +174%
🎯 on BSX : 0% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Oct 1, 26
matures : Oct 1, 26
Raymond James ↗
Jul 24, 25
▲ Strong Buy · 🎯$124
Price at call : $106.14 — upside +17%
Today : $46.67 — upside +166%
Expected +17% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
-57.1%
stock -57% · XLV +20%
matured Jul 24, 26
Truist Securities ↗
Jul 24, 25
▲ Buy · 🎯$125
Price at call : $106.21 — upside +18%
Today : $46.67 — upside +168%
Expected +18% · Actual -58% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-58.3%
stock -58% · XLV +20%
matured Jul 24, 26
Leerink Partners ↗
Jun 16, 25
▲ Outperform · 🎯$118
Price at call : $101.49 — upside +16%
Today : $46.67 — upside +153%
Expected +16% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 0% (1 call matured) · 📊 on Health : 55.3% · -4.8% (38 calls)
-53.8%
stock -54% · XLV +13%
matured Jun 16, 26
Raymond James ↗
Apr 24, 25
▲ Strong Buy · 🎯$121
Price at call : $101.9 — upside +19%
Today : $46.67 — upside +159%
Expected +19% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
-41.2%
stock -41% · XLV +4%
matured Apr 24, 26
Truist Securities ↗
Apr 24, 25
▲ Buy · 🎯$117
Price at call : $101.9 — upside +15%
Today : $46.67 — upside +151%
Expected +15% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-41.2%
stock -41% · XLV +4%
matured Apr 24, 26
▲ Buy · 🎯$124
Price at call : $101.14 — upside +23%
Today : $46.67 — upside +166%
Expected +23% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-38.6%
stock -39% · XLV +5%
matured Apr 23, 26
Truist Securities ↗
Apr 11, 25
▲ Buy · 🎯$113
Price at call : $93.67 — upside +21%
Today : $46.67 — upside +142%
Expected +21% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-32.6%
stock -33% · XLV +8%
matured Apr 11, 26
Truist Securities ↗
Feb 6, 25
▲ Buy · 🎯$120
Price at call : $105.25 — upside +14%
Today : $46.67 — upside +157%
Expected +14% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
-29.6%
stock -30% · XLV +7%
matured Feb 6, 26
Canaccord Genuity ↗
Feb 6, 25
▲ Buy · 🎯$117
Price at call : $105.25 — upside +11%
Today : $46.67 — upside +151%
Expected +11% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-29.6%
stock -30% · XLV +7%
matured Feb 6, 26
Raymond James ↗
Feb 6, 25
▲ Strong Buy · 🎯$122
Price at call : $105.25 — upside +16%
Today : $46.67 — upside +161%
Expected +16% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
-29.6%
stock -30% · XLV +7%
matured Feb 6, 26
Raymond James ↗
Jan 31, 25
▲ Strong Buy · 🎯$119
Price at call : $103.07 — upside +15%
Today : $46.67 — upside +155%
Expected +15% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
-10.9%
stock -11% · XLV +6%
matured Jan 31, 26
Truist Securities ↗
Dec 18, 24
▲ Buy · 🎯$110
Price at call : $88.03 — upside +25%
Today : $46.67 — upside +136%
Expected +25% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+9.2%
stock +9% · XLV +12%
matured Dec 18, 25
Canaccord Genuity ↗
Dec 9, 24
▲ Buy · 🎯$101
Price at call : $90.2 — upside +12%
Today : $46.67 — upside +116%
Expected +12% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+2.8%
stock +3% · XLV +6%
matured Dec 9, 25
Canaccord Genuity ↗
Oct 24, 24
▲ Buy · 🎯$98
Price at call : $85.1 — upside +15%
Today : $46.67 — upside +110%
Expected +15% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+18.8%
stock +19% · XLV -2%
matured Oct 24, 25
Canaccord Genuity ↗
Oct 21, 24
▲ Buy · 🎯$98
Price at call : $88.05 — upside +11%
Today : $46.67 — upside +110%
Expected +11% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+13.5%
stock +13% · XLV -4%
matured Oct 21, 25
▲ Buy · 🎯$93
Price at call : $86.77 — upside +7%
Today : $46.67 — upside +99%
Expected +7% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+12.6%
stock +13% · XLV -7%
matured Oct 14, 25
Truist Securities ↗
Oct 14, 24
▲ Buy · 🎯$100
Price at call : $86.77 — upside +15%
Today : $46.67 — upside +114%
Expected +15% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+12.6%
stock +13% · XLV -7%
matured Oct 14, 25
Raymond James ↗
Sep 4, 24
▲ Strong Buy · 🎯$94
Price at call : $81.96 — upside +15%
Today : $46.67 — upside +101%
Expected +15% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+30.9%
stock +31% · XLV -12%
matured Sep 4, 25
Raymond James ↗
Jul 25, 24
▲ Strong Buy · 🎯$91
Price at call : $74.92 — upside +21%
Today : $46.67 — upside +95%
Expected +21% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+41.3%
stock +41% · XLV -10%
matured Jul 25, 25
Canaccord Genuity ↗
Jul 25, 24
▲ Buy · 🎯$88
Price at call : $74.26 — upside +19%
Today : $46.67 — upside +89%
Expected +19% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+42.9%
stock +43% · XLV -8%
matured Jul 25, 25
Truist Securities ↗
Jul 16, 24
▲ Buy · 🎯$90
Price at call : $77.41 — upside +16%
Today : $46.67 — upside +93%
Expected +16% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+35.2%
stock +35% · XLV -12%
matured Jul 16, 25
▲ Buy · 🎯$84
Price at call : $78.14 — upside +7%
Today : $46.67 — upside +80%
Expected +7% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+32.1%
stock +32% · XLV -10%
matured Jul 15, 25
Raymond James ↗
Apr 25, 24
▲ Strong Buy · 🎯$85
Price at call : $73.17 — upside +16%
Today : $46.67 — upside +82%
Expected +16% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+39.6%
stock +40% · XLV -1%
matured Apr 25, 25
Raymond James ↗
Feb 1, 24
▲ Strong Buy · 🎯$73
Price at call : $64.82 — upside +13%
Today : $46.67 — upside +56%
Expected +13% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+57.9%
stock +58% · XLV +3%
matured Jan 31, 25
Raymond James ↗
Jan 3, 24
▲ Strong Buy · 🎯$67
Price at call : $58.17 — upside +15%
Today : $46.67 — upside +44%
Expected +15% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+55.9%
stock +56% · XLV -0%
matured Jan 2, 25
▲ Buy · 🎯$64
Price at call : $57.81 — upside +11%
Today : $46.67 — upside +37%
Expected +11% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+55.1%
stock +55% · XLV +1%
matured Dec 28, 24
Truist Securities ↗
Dec 22, 23
▲ Buy · 🎯$66
Price at call : $55.99 — upside +18%
Today : $46.67 — upside +41%
Expected +18% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+60.5%
stock +60% · XLV +3%
matured Dec 21, 24
Canaccord Genuity ↗
Nov 27, 23
▲ Buy · 🎯$64
Price at call : $54.93 — upside +17%
Today : $46.67 — upside +37%
Expected +17% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+65.2%
stock +65% · XLV +13%
matured Nov 26, 24
Truist Securities ↗
Sep 21, 23
▲ Buy · 🎯$61
Price at call : $53.6 — upside +14%
Today : $46.67 — upside +31%
Expected +14% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+56.7%
stock +57% · XLV +19%
matured Sep 20, 24
Canaccord Genuity ↗
Sep 21, 23
▲ Buy · 🎯$64
Price at call : $53.6 — upside +19%
Today : $46.67 — upside +37%
Expected +19% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+56.7%
stock +57% · XLV +19%
matured Sep 20, 24
▲ Buy · 🎯$64
Price at call : $53.6 — upside +19%
Today : $46.67 — upside +37%
Expected +19% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+56.7%
stock +57% · XLV +19%
matured Sep 20, 24
Canaccord Genuity ↗
Jul 28, 23
▲ Buy · 🎯$62
Price at call : $51.85 — upside +20%
Today : $46.67 — upside +33%
Expected +20% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+45.8%
stock +46% · XLV +12%
matured Jul 27, 24
Raymond James ↗
Jul 28, 23
▲ Strong Buy · 🎯$61
Price at call : $51.69 — upside +18%
Today : $46.67 — upside +31%
Expected +18% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+46.2%
stock +46% · XLV +11%
matured Jul 27, 24
Truist Securities ↗
Jul 19, 23
▲ Buy · 🎯$61
Price at call : $53.46 — upside +14%
Today : $46.67 — upside +31%
Expected +14% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+45.1%
stock +45% · XLV +10%
matured Jul 18, 24
Canaccord Genuity ↗
Apr 27, 23
▲ Buy · 🎯$58
Price at call : $52.03 — upside +11%
Today : $46.67 — upside +24%
Expected +11% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+40.6%
stock +41% · XLV +6%
matured Apr 26, 24
▲ Buy · 🎯$54
Price at call : $51.61 — upside +5%
Today : $46.67 — upside +16%
Expected +5% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+31.7%
stock +32% · XLV +4%
matured Apr 16, 24
Truist Securities ↗
Apr 17, 23
▲ Buy · 🎯$59
Price at call : $51.74 — upside +14%
Today : $46.67 — upside +26%
Expected +14% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+31.7%
stock +32% · XLV +3%
matured Apr 16, 24
Raymond James ↗
Apr 17, 23
▲ Strong Buy · 🎯$60
Price at call : $51.74 — upside +16%
Today : $46.67 — upside +29%
Expected +16% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+31.7%
stock +32% · XLV +3%
matured Apr 16, 24
Raymond James ↗
Feb 2, 23
▲ Strong Buy · 🎯$56
Price at call : $48.07 — upside +16%
Today : $46.67 — upside +20%
Expected +16% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 46.5% · +1.6% (402 calls)
+33.9%
stock +34% · XLV +7%
matured Feb 2, 24
Truist Securities ↗
Dec 20, 22
▲ Buy · 🎯$54
Price at call : $45.84 — upside +18%
Today : $46.67 — upside +16%
Expected +18% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 67% (12 calls matureds) · 📊 on Health : 49.6% · +2.3% (260 calls)
+19.9%
stock +20% · XLV -1%
matured Dec 20, 23
▲ Buy · 🎯$50
Price at call : $41.16 — upside +21%
Today : $46.67 — upside +7%
Expected +21% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+25.6%
stock +26% · XLV +2%
matured Jul 28, 23
Canaccord Genuity ↗
Jun 29, 22
▲ Buy · 🎯$43
Price at call : $37.27 — upside +15%
Today : $46.67 — upside -8%
Expected +15% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+45.1%
stock +45% · XLV +4%
matured Jun 29, 23
▲ Buy · 🎯$45
Price at call : $38.02 — upside +18%
Today : $46.67 — upside -4%
Expected +18% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+40.7%
stock +41% · XLV +2%
matured Jun 24, 23
Canaccord Genuity ↗
Jun 27, 19
▲ Buy · 🎯$46
Price at call : $42.98 — upside +7%
Today : $46.67 — upside -1%
Expected +7% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-19.4%
stock -19% · XLV +6%
matured Jun 26, 20
Canaccord Genuity ↗
Apr 17, 19
▲ Buy · 🎯$43
Price at call : $35.11 — upside +22%
Today : $46.67 — upside -8%
Expected +22% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on BSX : 83% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+9.1%
stock +9% · XLV +17%
matured Apr 16, 20
▲ Buy
Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on BSX : 90% (10 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+43.3%
stock +43% · XLV +15%
matured Nov 30, 18
Frequently asked questions
Should I buy Boston Scientific stock?
This isn't buy advice. For Boston Scientific, the analyst consensus is "Buy", with an average price target of $67.00 (+44% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Boston Scientific). We show the numbers — you decide.
Is it too late to buy Boston Scientific? How high can it go?
The most bullish analyst target on Boston Scientific is $89.00 (+91% above today's price); the average is $67.00. That's the upside they see. Check how reliable those analysts have actually been on Boston Scientific on our site before trusting it.
Is Boston Scientific still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 29 analysts have a real record on Boston Scientific, the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Will Boston Scientific stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will BSX stock recover (go back up)?
Should you invest in Boston Scientific? The case for and against
The arguments for and against, one by one, from the numbers: why invest in BSX (and why hesitate).
What has Boston Scientific's past performance been?
Historical returns and a "how much if I had invested" calculator: BSX performance & returns.
What is the best month to buy BSX?
The 12 months ranked by the stock's past returns: best & worst month to buy BSX.
Are insiders buying BSX stock?
Executives' and large holders' buys and sells, decoded: insider buying on BSX.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
LLY